Dow Jones-the German stock market closed on Thursday with losses. The DAX lost 0.5 percent to 23,999 points, but was clearly over the daily low at 23,843. The US bond market was in view. A weakly running auction 20-year-old US state bonds the day before illustrated the unwillingness of the market to borrow the United States at the current interest. On the reporting day, the US House of Representatives then approved President Donald Trump’s tax and expenditure law. The issue of expenditure would continue to increase the US state debt in the coming year. The US Senate still has to approve the draft law.
In the afternoon, the market interest rates came back from the day highs, which ensured a certain relaxation on the stock exchanges, but remained at an increased level. For example, around 30-year US state bonds paid at 5.08 percent, and thus only insignificantly below the annual high at 5.15 percent. After the announcement of better US shopping managers, the DAX then recovered from the daily lows.
Company reports played a subordinate role in the environment. Bayer was able to escape the downward trend on the overall market and won 2.7 percent. The sentiment for the share was now supported by the message about the approval of the eye medication Eylea in the high -dose variant in China for the treatment of damp age -dependent macular degeneration. UBS estimates the income with Eylea in the current year at a total of 3.12 billion euros.
ProSieben advises shareholders to reject MFE bid
ProSieben’s invitation to shareholders was positively received by the shareholders not to accept MFE’s purchase offer. “Something like that always sounds like bidding and increased offers,” said a dealer. Therefore, it is advisable for free shareholders to simply continue to wait. It will only be interesting when the board and the Supervisory Board together recommend accepting a bid. The shares climbed by 1.1 percent to 7.08 euros. The offer of MFE only results in a price of 5.75 euros in the current MFE course, it said from ProSieben.
The figures were cautiously commented on by CTS Eventim (-6.2%) for the first quarter. “The numbers are good, but they could no longer meet the high expectations,” said a dealer. While the CTS turnover attracted significantly, there was strong pressure on the EBITDA margin. The result per share therefore remained clearly under the previous year’s quarter.
Freenet pressed profit from 16.7 percent. The numbers for the first quarter are okay, but unspectacular, it said. The annual forecast was not increased, but only confirmed. Oddo BHF lowered the paper on “Under Perperform”.
===
Index last +/- % +/- % ytd
DAX 23,999.17 -0.5% +20.7%
DAX-Future 24,056.00 +0.4% +18.7%
XDAX 24.005.38 +0.4% +21.3%
MDAX 30,053.54 -1.3% +19.4%
TECDAX 3,846.76 -1.0% +13.3%
SDAX 16,423,28 -1.4% +22.2%
last +/- ticks
BUND-FUTURE 129.96 +31
YTD – based on the final course the previous day
Index Winner Loser Unv. Sales Mio Mio Mio Mio Shares
DAX 8 30 2 2,191.8 29.4
MDax 9 40 1 632.1 28.6
Tecdax 3 26 1 944.7 21.2
SDAX 10 54 6 256.0 12.5
===
Contact with the author: [email protected]
DJG/MPT/CLN
(End) Dow Jones Newswires
May 22, 2025 11:45 ET (15:45 GMT)